Oppenheimer Initiates Coverage On Gossamer Bio with Outperform Rating, Announces Price Target of $9
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer has initiated coverage on Gossamer Bio (NASDAQ:GOSS) with an Outperform rating and set a price target of $9.
June 25, 2024 | 9:40 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Oppenheimer has initiated coverage on Gossamer Bio with an Outperform rating and a price target of $9, indicating a positive outlook for the stock.
The initiation of coverage with an Outperform rating and a price target of $9 by a reputable firm like Oppenheimer is likely to boost investor confidence and positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100